Sharon Mates - Chairman and CEO, Director at Intra-Cellular Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and CEO, Director
Stock Symbol
ITCI on Nasdaq
All Insider Reports
All Insider Reports

Sharon Mates - trading volume in the past year for Intra-Cellular Therapies, Inc.

Holdings reported by Sharon Mates for Intra-Cellular Therapies, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.07M $78.5M $73.32 Aug 30, 2024 Direct
Restricted Stock Units 20.6K $1.38M $67.12 Mar 10, 2024 Direct Common Stock
Stock Option (right to buy) 103K Aug 30, 2024 Direct Common Stock

Transactions reported by Sharon Mates for Intra-Cellular Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.